デジタル治療薬市場：適応症別、成分別、流通別-2023-2030年の世界予測

デジタル治療薬の世界市場は、2023年に46億5,809万米ドル、CAGR 23.80%で大きく成長し、2030年には207億9,266万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界のデジタル治療薬市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.デジタル治療薬の世界市場規模および予測は？

2.予測期間中、世界のデジタル治療薬市場を形成するCOVID-19の阻害要因と影響は？

3.デジタル治療薬の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.デジタル治療薬の世界市場における競争戦略は？

5.デジタル治療薬の世界市場における技術動向と規制の枠組みは？

6.デジタル治療薬の世界市場における主要ベンダーの市場シェアは？

7.デジタル治療薬の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 予防的慢性疾患の発生率の増加
    • スマートフォンやタブレットとヘルスケアアプリの併用
    • 遠隔医療と遠隔医療を促進する政府の取り組み
  • 抑制要因
    • 新興経済諸国におけるデジタル治療薬に関する認識が限定的
  • 機会
    • デジタルヘルス事業の拡大に向けた資金調達と投資の増加
    • デジタル治療薬の新技術
  • 課題
    • データのプライバシーとセキュリティに関する懸念
• 市場動向
• COVID-19の累積的な影響
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み
• 顧客のカスタマイズ

第6章 デジタル治療薬市場適応症別

• 循環器疾患
• 中枢神経系障害
• 慢性呼吸器疾患
• 糖尿病
• 服薬アドヒアランス
• 筋骨格系疾患
• 肥満
• 前糖尿病
• 禁煙

第7章 デジタル治療薬市場：コンポーネント別

• デバイス
• ソフトウェア

第8章 デジタル治療薬市場配信別

• B2B
  • 雇用者
  • 支払者
  • 製薬会社
  • プロバイダー
• B2C
  • 介護者
  • 患者

第9章 南北アメリカのデジタル治療薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のデジタル治療薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのデジタル治療薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ分析：主要企業別
  • 合併・買収

第13章 掲載企業一覧

第14章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. DIGITAL THERAPEUTICS MARKET RESEARCH PROCESS
• FIGURE 2. DIGITAL THERAPEUTICS MARKET SIZE, 2022 VS 2030
• FIGURE 3. DIGITAL THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
• FIGURE 5. DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2022 VS 2030 (%)
• FIGURE 6. DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2022 VS 2030 (%)
• FIGURE 7. DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 8. DIGITAL THERAPEUTICS MARKET DYNAMICS
• FIGURE 9. DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. DIGITAL THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 17. DIGITAL THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. DIGITAL THERAPEUTICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. DIGITAL THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 5. DIGITAL THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. DIGITAL THERAPEUTICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. DIGITAL THERAPEUTICS MARKET SIZE, BY CHRONIC RESPIRATORY DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. DIGITAL THERAPEUTICS MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. DIGITAL THERAPEUTICS MARKET SIZE, BY MEDICATION ADHERENCE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. DIGITAL THERAPEUTICS MARKET SIZE, BY MUSCULOSKELETAL DISORDER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. DIGITAL THERAPEUTICS MARKET SIZE, BY OBESITY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. DIGITAL THERAPEUTICS MARKET SIZE, BY PREDIABETES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. DIGITAL THERAPEUTICS MARKET SIZE, BY SMOKING CESSATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 15. DIGITAL THERAPEUTICS MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. DIGITAL THERAPEUTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 18. DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
• TABLE 19. DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. DIGITAL THERAPEUTICS MARKET SIZE, BY EMPLOYER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. DIGITAL THERAPEUTICS MARKET SIZE, BY PAYER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. DIGITAL THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL COMPANY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. DIGITAL THERAPEUTICS MARKET SIZE, BY PROVIDER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
• TABLE 25. DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. DIGITAL THERAPEUTICS MARKET SIZE, BY CAREGIVER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. DIGITAL THERAPEUTICS MARKET SIZE, BY PATIENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
• TABLE 44. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 45. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 46. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 47. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
• TABLE 48. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
• TABLE 70. AUSTRALIA DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
• TABLE 71. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 72. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 73. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 74. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
• TABLE 75. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
• TABLE 76. INDIA DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 77. INDIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 78. INDIA DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 79. INDIA DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
• TABLE 80. INDIA DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
• TABLE 85. INDONESIA DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
• TABLE 90. JAPAN DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
• TABLE 95. MALAYSIA DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
• TABLE 100. PHILIPPINES DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
• TABLE 105. SINGAPORE DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
• TABLE 110. SOUTH KOREA DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
• TABLE 115. TAIWAN DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
• TABLE 120. THAILAND DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
• TABLE 125. VIETNAM DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
• TABLE 136. DENMARK DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
• TABLE 141. EGYPT DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
• TABLE 146. FINLAND DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
• TABLE 151. FRANCE DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
• TABLE 156. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
• TABLE 161. ISRAEL DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
• TABLE 162. ITALY DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 163. ITALY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 164. ITALY DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 165. ITALY DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
• TABLE 166. ITALY DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
• TABLE 171. NETHERLANDS DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
• TABLE 176. NIGERIA DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
• TABLE 181. NORWAY DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
• TABLE 182. POLAND DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 183. POLAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 184. POLAND DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 185. POLAND DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
• TABLE 186. POLAND DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
• TABLE 187. QATAR DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 188. QATAR DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 189. QATAR DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 190. QATAR DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
• TABLE 191. QATAR DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
• TABLE 196. RUSSIA DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
• TABLE 201. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
• TABLE 206. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
• TABLE 211. SPAIN DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
• TABLE 216. SWEDEN DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
• TABLE 221. SWITZERLAND DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
• TABLE 226. TURKEY DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
• TABLE 231. UNITED ARAB EMIRATES DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
• TABLE 236. UNITED KINGDOM DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
• TABLE 237. DIGITAL THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 238. DIGITAL THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 239. DIGITAL THERAPEUTICS MARKET LICENSE & PRICING

The Global Digital Therapeutics Market is forecasted to grow significantly, with a projected USD 4,658.09 million in 2023 at a CAGR of 23.80% and expected to reach a staggering USD 20,792.66 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Digital Therapeutics Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Digital Therapeutics Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Indication, market is studied across Cardiovascular Disease, Central Nervous System Disorder, Chronic Respiratory Disease, Diabetes, Medication Adherence, Musculoskeletal Disorder, Obesity, Prediabetes, and Smoking Cessation. The Obesity is projected to witness significant market share during forecast period.

Based on Component, market is studied across Devices and Software. The Devices is projected to witness significant market share during forecast period.

Based on Distribution, market is studied across B2B and B2C. The B2B is further studied across Employer, Payer, Pharmaceutical Company, and Provider. The B2C is further studied across Caregiver and Patient. The B2B is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Digital Therapeutics Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Digital Therapeutics Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Digital Therapeutics Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Digital Therapeutics Market?

4. What is the competitive strategic window for opportunities in the Global Digital Therapeutics Market?

5. What are the technology trends and regulatory frameworks in the Global Digital Therapeutics Market?

6. What is the market share of the leading vendors in the Global Digital Therapeutics Market?

7. What modes and strategic moves are considered suitable for entering the Global Digital Therapeutics Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Digital Therapeutics Market, by Indication, 2022 vs 2030
• 4.3. Digital Therapeutics Market, by Component, 2022 vs 2030
• 4.4. Digital Therapeutics Market, by Distribution, 2022 vs 2030
• 4.5. Digital Therapeutics Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidences of preventive chronic diseases
    • 5.1.1.2. Adoption of smartphones and tablets coupled with healthcare apps
    • 5.1.1.3. Government initiatives promoting telehealth and telemedicine
  • 5.1.2. Restraints
    • 5.1.2.1. Limited awareness regarding digital therapeutics in the developing economies
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising funding and investments for expanding digital health businesses
    • 5.1.3.2. New technologies in digital therapeutics
  • 5.1.4. Challenges
    • 5.1.4.1. Data privacy and security concerns
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Digital Therapeutics Market, by Indication

• 6.1. Introduction
• 6.2. Cardiovascular Disease
• 6.3. Central Nervous System Disorder
• 6.4. Chronic Respiratory Disease
• 6.5. Diabetes
• 6.6. Medication Adherence
• 6.7. Musculoskeletal Disorder
• 6.8. Obesity
• 6.9. Prediabetes
• 6.10. Smoking Cessation

7. Digital Therapeutics Market, by Component

• 7.1. Introduction
• 7.2. Devices
• 7.3. Software

8. Digital Therapeutics Market, by Distribution

• 8.1. Introduction
• 8.2. B2B
  • 8.2.1. Employer
  • 8.2.2. Payer
  • 8.2.3. Pharmaceutical Company
  • 8.2.4. Provider
• 8.3. B2C
  • 8.3.1. Caregiver
  • 8.3.2. Patient

9. Americas Digital Therapeutics Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Digital Therapeutics Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Digital Therapeutics Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. FPNV Positioning Matrix
• 12.2. Market Share Analysis, By Key Player
• 12.3. Competitive Scenario Analysis, By Key Player
  • 12.3.1. Merger & Acquisition
    • 12.3.1.1. Pfizer in Early Stage Talks to Acquire Seagen

13. List of Company Mentioned

14. Appendix

• 14.1. Discussion Guide
• 14.2. License & Pricing